- Home
- ADPT vs EFSC Comparison
ADPT vs EFSC Comparison
Compare ADPT & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- EFSC
- Stock Information
- Founded
- ADPT 2009
- EFSC 1988
- Country
- ADPT United States
- EFSC United States
- Employees
- ADPT N/A
- EFSC N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- EFSC Major Banks
- Sector
- ADPT Health Care
- EFSC Finance
- Exchange
- ADPT Nasdaq
- EFSC Nasdaq
- Market Cap
- ADPT 1.8B
- EFSC 2.1B
- IPO Year
- ADPT 2019
- EFSC 1999
- Fundamental
- Price
- ADPT $10.75
- EFSC $55.92
- Analyst Decision
- ADPT Strong Buy
- EFSC Strong Buy
- Analyst Count
- ADPT 7
- EFSC 3
- Target Price
- ADPT $10.57
- EFSC $64.33
- AVG Volume (30 Days)
- ADPT 2.1M
- EFSC 185.2K
- Earning Date
- ADPT 08-05-2025
- EFSC 07-28-2025
- Dividend Yield
- ADPT N/A
- EFSC 2.15%
- EPS Growth
- ADPT N/A
- EFSC 9.23
- EPS
- ADPT N/A
- EFSC 5.09
- Revenue
- ADPT $189,527,000.00
- EFSC $619,222,000.00
- Revenue This Year
- ADPT $24.39
- EFSC $13.90
- Revenue Next Year
- ADPT $20.44
- EFSC $4.64
- P/E Ratio
- ADPT N/A
- EFSC $10.96
- Revenue Growth
- ADPT 8.61
- EFSC 6.50
- 52 Week Low
- ADPT $3.85
- EFSC $45.22
- 52 Week High
- ADPT $12.43
- EFSC $63.13
- Technical
- Relative Strength Index (RSI)
- ADPT 48.31
- EFSC 47.27
- Support Level
- ADPT $10.22
- EFSC $56.49
- Resistance Level
- ADPT $11.18
- EFSC $59.38
- Average True Range (ATR)
- ADPT 0.51
- EFSC 1.39
- MACD
- ADPT -0.15
- EFSC -0.30
- Stochastic Oscillator
- ADPT 24.82
- EFSC 12.63
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.